Harborside


Vext Science, Inc.

CNSX: VEXT


Canadian symbol: VEXT.CN
US symbol: VEXTF

Currency in CAD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 2.38
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 30.9200
52 Week Low 30.3500
50-Day Moving Average 30.4449
200-Day Moving Average 30.6159

Share Statistics

Avg Vol (3 month) 345.77k
Avg Vol (10 day) 336.68k
Shares Outstanding 568.56M
Implied Shares Outstanding 6N/A
Float 868.16M
% Held by Insiders 112.55%
% Held by Institutions 119.06%
Shares Short (Apr 13, 2022) 443.06k
Short Ratio (Apr 13, 2022) 41.72
Short % of Float (Apr 13, 2022) 4N/A
Short % of Shares Outstanding (Apr 13, 2022) 40.06%
Shares Short (prior month Mar 14, 2022) 438.64k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021

Profitability

Profit Margin 13.39%
Operating Margin (ttm)21.45%

Management Effectiveness

Return on Assets (ttm)7.18%
Return on Equity (ttm)10.42%

Income Statement

Revenue (ttm)37.24M
Revenue Per Share (ttm)0.27
Quarterly Revenue Growth (yoy)45.20%
Gross Profit (ttm)18.42M
EBITDA 11.25M
Net Income Avi to Common (ttm)4.99M
Diluted EPS (ttm)0.0490
Quarterly Earnings Growth (yoy)-3.70%

Balance Sheet

Total Cash (mrq)6.47M
Total Cash Per Share (mrq)0.05
Total Debt (mrq)14.1M
Total Debt/Equity (mrq)23.74
Current Ratio (mrq)3.20
Book Value Per Share (mrq)0.42

Cash Flow Statement

Operating Cash Flow (ttm)11.68M
Levered Free Cash Flow (ttm)-11.34M

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Cannabis Market and Business News

Real-time cannabis business news from hundreds of sources. Never miss the news that matters the most.




Company News Date
VEXT.CN
Vext Science
2 weeks ago
VEXT.CN
Vext Science
1 month ago
VEXT.CN
Vext Science
2 months ago
VEXT.CN
Vext Science
2 months ago
VEXT.CN
Vext Science
6 months ago
VEXT.CN
Vext Science
7 months ago
VEXT.CN
Vext Science
7 months ago
VEXT.CN
Vext Science
8 months ago
VEXT.CN
Vext Science
10 months ago
VEXT.CN
Vext Science
10 months ago
VEXT.CN
Vext Science
10 months ago
VEXT.CN
Vext Science
11 months ago
VEXT.CN
Vext Science
1 year ago
VEXT.CN
Vext Science
1 year ago
VEXT.CN
Vext Science
1 year ago
VEXT.CN
Vext Science
1 year ago
VEXT.CN
Vext Science
1 year ago
VEXT.CN
Vext Science
1 year ago
VEXT.CN
Vext Science
1 year ago
VEXT.CN
Vext Science
1 year ago
VEXT.CN
Vext Science
2 years ago
VEXT.CN
Vext Science
2 years ago
VEXT.CN
Vext Science
2 years ago
VEXT.CN
Vext Science
2 years ago
VEXT.CN
Vext Science
2 years ago
VEXT.CN
Vext Science
2 years ago
VEXT.CN
Vext Science
2 years ago
VEXT.CN
Vext Science
2 years ago
VEXT.CN
Vext Science
2 years ago
VEXT.CN
Vext Science
2 years ago
VEXT.CN
Vext Science
2 years ago
VEXT.CN
Vext Science
2 years ago
VEXT.CN
Vext Science
2 years ago
VEXT.CN
Vext Science
2 years ago
VEXT.CN
Vext Science
2 years ago
VEXT.CN
Vext Science
3 years ago
VEXT.CN
Vext Science
3 years ago
VEXT.CN
Vext Science
3 years ago

Currency in CAD
Earnings EstimateCurrent Qtr. (Mar 2022)Next Qtr. (Jun 2022)Current Year (2022)Next Year (2023)
No. of Analysts1133
Avg. Estimate000.030.07
Low Estimate000.010.05
High Estimate000.050.09
Year Ago EPSN/A0.010.040.03
Revenue EstimateCurrent Qtr. (Mar 2022)Next Qtr. (Jun 2022)Current Year (2022)Next Year (2023)
No. of Analysts4344
Avg. Estimate12.87M13.57M55.85M73.36M
Low Estimate12.42M12.8M52.12M62.74M
High Estimate13.44M13.96M58.65M82.98M
Year Ago Sales11.52M11.28M46.68M55.85M
Sales Growth (year/est)11.70%20.30%19.60%31.40%
Earnings HistoryInvalid Date2021-06-292021-09-292021-12-30
EPS Est.N/A0.010.010.01
EPS ActualN/A0.010.010.01
DifferenceN/A000
Surprise %N/A0.00%0.00%0.00%
EPS TrendCurrent Qtr. (Mar 2022)Next Qtr. (Jun 2022)Current Year (2022)Next Year (2023)
Current Estimate000.030.07
7 Days Ago000.030.07
30 Days Ago000.040.08
60 Days Ago000.040.07
90 Days Ago000.040.07
EPS RevisionsCurrent Qtr. (Mar 2022)Next Qtr. (Jun 2022)Current Year (2022)Next Year (2023)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesVEXT.CNIndustrySector(s)S&P 500
Current Qtr.N/AN/AN/AN/A
Next Qtr.-100.00%N/AN/AN/A
Current Year-25.00%N/AN/AN/A
Next Year133.30%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
12.55%% of Shares Held by All Insider
19.06%% of Shares Held by Institutions
21.80%% of Float Held by Institutions
7Number of Institutions Holding Shares

Top Institutional Holders

HolderSharesDate Reported% OutValue
Gofen & Glossberg LLC100,000Mar 30, 20220.14%60,000
Gofen & Glossberg LLC100,000Mar 30, 20220.14%60,000
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by Vext Science, Inc.


Vext Announces CFO Transition

Vext Announces CFO Transition

Daniel Engel is leaving the Company for a senior role at a private company. Stephan Bankosz, current CFO of the Company's primary operating subsidiary, will take over as interim CFO and Corporate Secretary of Vext, effective immediately. VANCOUVER, BC, June 15, 2022 - Vext Science, Inc. ("Vext") (CSE: VEXT) (OTCQX: VEXTF) a cannabinoid... Read More...
Vext Announces Strong Growth for 2021

Vext Announces Strong Growth for 2021

Revenue of $37.2 Million up 48%, Adjusted EBITDA of $13.4 Million up 100% Q4-2021 revenue of $9.3 million, +45% vs. Q4-2020; Adjusted EBITDA of $3.4 million, +47% vs. prior year period. Cash flow from operations was $4.8 million. FY-2021 revenue of $37.2 million, + 48% vs. FY-2020; Adjusted EBITDA of $13.4 million, +100% vs. prior year p... Read More...
Vext to Announce Financial Results for Q4 and Fiscal 2021 on April 20, 2022

Vext to Announce Financial Results for Q4 and Fiscal 2021 on April 20, 2022

Management to hold conference call on April 20 to review financial results and host Q&A  VANCOUVER, BC, April 14, 2022 - Vext Science, Inc. ("Vext") (CSE: VEXT) (OTCQX: VEXTF), a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-... Read More...
Vext Announces Appointment of Highly Experienced Global Executive and Director Mark W. Opzoomer to the Company's Board of Directors

Vext Announces Appointment of Highly Experienced Global Executive and Director Mark W. Opzoomer to the Company’s Board of Directors

VANCOUVER, BC, Feb. 10, 2022 - Vext Science, Inc. ("Vext") (CSE: VEXT) (OTCQX: VEXTF), a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-state footprint, today announced that Mark W. Opzoomer, a highly experienced global executive ... Read More...
Vext Science to Hold Conference Call to Review its Third Quarter 2021 Financial Results

Vext Science to Hold Conference Call to Review its Third Quarter 2021 Financial Results

VANCOUVER, BC, Nov. 5, 2021 - Vext Science, Inc. ("Vext") (CSE: VEXT) (OTCQX: VEXTF) a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-state footprint, announced today that it will host a conference call and webcast Thursday Novemb... Read More...
Vext Science to Present at AGP's Virtual Fall Consumer Cannabis Conference 2021

Vext Science to Present at AGP’s Virtual Fall Consumer Cannabis Conference 2021

VANCOUVER, BC, Sept. 30, 2021 - Vext Science, Inc. ("Vext") (CSE: VEXT) (OTCQX: VEXTF) a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-state footprint, announced today that it will participate in Alliance Global Partners' (A.G.P.... Read More...
Vext Science to Hold Conference Call to Review its Second Quarter 2021 Financial Results

Vext Science to Hold Conference Call to Review its Second Quarter 2021 Financial Results

VANCOUVER, BC, Aug. 11, 2021 - Vext Science, Inc. ("Vext") (CSE: VEXT) (OTCQX: VEXTF) a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-state footprint, announced today that it will host a conference call and webcast Tuesday August... Read More...
Vext Science Signs MOU with SōRSE Technology to Sell MAJOR Cannabis Infused Beverages in Arizona

Vext Science Signs MOU with SōRSE Technology to Sell MAJOR Cannabis Infused Beverages in Arizona

MAJOR was the top selling cannabis beverage brand in the U.S. during Q1 20211 VANCOUVER, BC, July 6, 2021 - Vext Science, Inc. ("Vext") (CSE: VEXT) (OTCQX: VEXTF) a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-state footprin... Read More...
Vext Science Closes Purchase of 72,000 Square Foot Eloy, Arizona Cultivation Facility

Vext Science Closes Purchase of 72,000 Square Foot Eloy, Arizona Cultivation Facility

VANCOUVER, BC, June 25, 2021 - Vext Science, Inc. ("Vext") (CSE: VEXT) (OTCQX: VEXTF) a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-state footprint, today announced the closing of its purchase of a vacant 72,000 square foot ind... Read More...
Vext Science Receives Approval from the State of Arizona to Begin Operations in Newly Built-Out Manufacturing Facility

Vext Science Receives Approval from the State of Arizona to Begin Operations in Newly Built-Out Manufacturing Facility

Dedicated extraction and manufacturing space positions Vext to meet growth in volume at its operated dispensaries and increased sales of its wholly owned Vapen™ brand across the state. Four-fold increase in overall space includes additional extract and concentrates production space, a tripling of kitchen capacity, a re-designed finished... Read More...
Vext Science Receives Approval from The City of Eloy to Build-Out State of the Art 72,000 Square Foot Cultivation Facility

Vext Science Receives Approval from The City of Eloy to Build-Out State of the Art 72,000 Square Foot Cultivation Facility

Once the Eloy facility is operational, Vext will have total indoor capacity of ~58,000 square feet under canopy and 10 acres of outdoor capacity, to support growth in Arizona VANCOUVER, BC, May 11, 2021 - Vext Science, Inc. ("VEXT") (CSE: VEXT) (OTCQX: VEXTF) a cannabinoid brand leader based in Arizona, leveraging its core expertise in ... Read More...
Vext Enters into Agreements to Purchase Additional Cultivation Facility and Acquire Existing Operated Cultivation Facilities

Vext Enters into Agreements to Purchase Additional Cultivation Facility and Acquire Existing Operated Cultivation Facilities

Signs agreement to acquire 72,000 square foot industrial facility (~34,000 square feet of future canopy) located in Eloy, Arizona. Enters into separate agreements to acquire existing operated indoor cultivation facilities in Phoenix and Prescott Valley. Once the Eloy facility is operational, Vext will have total indoor capacity of ~58,... Read More...
VEXT Science to Participate in 2021 Benzinga Virtual Cannabis Capital Conference

VEXT Science to Participate in 2021 Benzinga Virtual Cannabis Capital Conference

VANCOUVER, BC, Feb. 22, 2021 - Vext Science, Inc. ("VEXT") (CSE: VEXT) (OTCQX: VEXTF) a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-state footprint, announced today that it will be participating in Benzinga's Cannabis Capital C... Read More...
Vext Announces Closing of Private Placement of Units for Gross Proceeds of $1.6 Million

Vext Announces Closing of Private Placement of Units for Gross Proceeds of $1.6 Million

/NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES OR TO A U.S. PERSON, OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION/ VANCOUVER, BC, Feb. 8, 2021 - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("VEXT"), a vertically i... Read More...
VEXT Announces Closing of Oversubscribed Public Offering of Units for Total Gross Proceeds of $20.7 Million

VEXT Announces Closing of Oversubscribed Public Offering of Units for Total Gross Proceeds of $20.7 Million

/NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES OR TO A U.S. PERSON, OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION/ VANCOUVER, BC, Feb. 8, 2021 - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("VEXT"), a vertically i... Read More...
Early Warning News Release - Sopica Global Retail Growth Fund, Ltd.'s and Sopica Special Opportunities Fund Limited's Holdings in VEXT Science, Inc.

Early Warning News Release – Sopica Global Retail Growth Fund, Ltd.’s and Sopica Special Opportunities Fund Limited’s Holdings in VEXT Science, Inc.

VANCOUVER, BC, Feb. 2, 2021 - This press release is being issued in connection with the filing of an early warning report (the "Early Warning Report") pursuant to the requirements of National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues regarding the acquisition (the "Acquisition") of... Read More...
Vext Files Preliminary Prospectus in Respect of Bought Deal Offering and Announces Concurrent Private Placement

Vext Files Preliminary Prospectus in Respect of Bought Deal Offering and Announces Concurrent Private Placement

/NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES OR TO A U.S. PERSON, OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION/ VANCOUVER, BC, Jan. 19, 2021 - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("VEXT"), a vertically ... Read More...
VEXT Appoints CFO for Arizona Subsidiary, New Gen Holdings, Inc., and Grant of Stock Options and RSUs

VEXT Appoints CFO for Arizona Subsidiary, New Gen Holdings, Inc., and Grant of Stock Options and RSUs

VANCOUVER, BC, Jan. 6, 2021 - Vext Science, Inc. ("VEXT") (CSE: VEXT) (OTCQX: VEXTF) a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-state footprint, announced today that it has appointed Stephan Bankosz as the Chief Financial Of... Read More...
Vext Announces Stock Option Grant

Vext Announces Stock Option Grant

VANCOUVER, BC, Nov. 27, 2020 - Vext Science, Inc. ("VEXT") (CSE: VEXT) (OTCQX: VEXTF) a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-state footprint, announced today that it has granted 375,000 stock options to certain employees... Read More...
Arizona Cannabis Operations Drive Adjusted EBITDA of US$2.6 Million, +60% vs. Q2-2020

Arizona Cannabis Operations Drive Adjusted EBITDA of US$2.6 Million, +60% vs. Q2-2020

Revenue of US$8.0 million, + 43% vs. US$5.6 million in Q3-2019; Adjusted EBITDA1 of US$2.6 million, +97% vs. US$1.3 million in the prior year period. With Arizona's transition to adult-use framework in early 2021, VEXT is fully funded for planned expansions and well positioned to continue driving growth and generating value for sharehol... Read More...
Vext Science Welcomes Arizona Approval of Legalized Possession of Marijuana for Adult Use

Vext Science Welcomes Arizona Approval of Legalized Possession of Marijuana for Adult Use

TORONTO, Oct. 26, 2020 - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce the impending launch of its suite of hard pill cannabinoid formulations in Australia ... Read More...
Vext Announces Closing of Oversubscribed Public Offering and Private Placement of Units for Total Gross Proceeds of $6.4 Million

Vext Announces Closing of Oversubscribed Public Offering and Private Placement of Units for Total Gross Proceeds of $6.4 Million

/NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES OR TO A U.S. PERSON, OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION./ VANCOUVER, BC, Nov. 2, 2020 - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("VEXT"), a vertically ... Read More...
VEXT SCIENCE Receives Approval from City of Phoenix for Expansion of Cultivation, Extraction and Production Footprints

VEXT SCIENCE Receives Approval from City of Phoenix for Expansion of Cultivation, Extraction and Production Footprints

/THIS NEWS RELEASE IS NOT INTENDED FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES./ Deepens the Company's commitment to the rapidly growing Arizona medical market, which is anticipated to shift to an adult-use market in 2021. Ensures consistent supply for the two Phoenix dispensaries opera... Read More...
VEXT SCIENCE Awarded Certificate of Occupancy for Additional Herbal Wellness Center Dispensary Location in Phoenix

VEXT SCIENCE Awarded Certificate of Occupancy for Additional Herbal Wellness Center Dispensary Location in Phoenix

/THIS NEWS RELEASE IS NOT INTENDED FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES./ Represents the Company's second exclusively-managed dispensary in the key Phoenix market – an important competitive advantage as the Arizona market evolves. Relationship expected to drive further awareness o... Read More...
VEXT SCIENCE Announces Joint Operation Agreement with Green Goblin, Inc. of San Diego California

VEXT SCIENCE Announces Joint Operation Agreement with Green Goblin, Inc. of San Diego California

/THIS NEWS RELEASE IS NOT INTENDED FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES./ Independent Equity Research Analyst Publishes Update with Rating Increase VANCOUVER, BC, June 11, 2020 - Vext Science, Inc. ("VEXT") (OTCQX: VEXTF) (CSE: VEXT) a cannabinoid brand leader leveraging core expert... Read More...
Vext Science, Inc. Grants Stock Options

Vext Science, Inc. Grants Stock Options

/THIS NEWS RELEASE IS NOT INTENDED FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES./ VANCOUVER, May 12, 2020 - Vext Science, Inc. ("VEXT" or the "Company") (OTCQX: VEXTF; CSE: VEXT) is pleased to announce that it has granted 1,083,334 stock options at an exercise price of CAD$0.75 to director... Read More...
Coming Soon.
IndexLast% Change
S&P 5003,911.74

3.06%Positive

Euro STOXX 503,533.17

2.82%Positive

FTSE 1007,208.81

2.68%Positive

Nikkei 22526,491.97

1.23%Positive


Delayed data (1h)
IndexLast% Change
S&P 5003,911.74

3.06%Positive

Euro STOXX 503,533.17

2.82%Positive

FTSE 1007,208.81

2.68%Positive

Nikkei 22526,491.97

1.23%Positive



Share this page